246 related articles for article (PubMed ID: 34301800)
21. The Role of PTEN in Innate and Adaptive Immunity.
Taylor H; Laurence ADJ; Uhlig HH
Cold Spring Harb Perspect Med; 2019 Dec; 9(12):. PubMed ID: 31501268
[TBL] [Abstract][Full Text] [Related]
22. Activation of PI3K/Akt/mTOR signaling pathway triggered by PTEN downregulation in the pathogenesis of Crohn's disease.
Long SH; He Y; Chen MH; Cao K; Chen YJ; Chen BL; Mao R; Zhang SH; Zhu ZH; Zeng ZR; Hu PJ
J Dig Dis; 2013 Dec; 14(12):662-9. PubMed ID: 23962154
[TBL] [Abstract][Full Text] [Related]
23. B cell activator PAX5 promotes lymphomagenesis through stimulation of B cell receptor signaling.
Cozma D; Yu D; Hodawadekar S; Azvolinsky A; Grande S; Tobias JW; Metzgar MH; Paterson J; Erikson J; Marafioti T; Monroe JG; Atchison ML; Thomas-Tikhonenko A
J Clin Invest; 2007 Sep; 117(9):2602-10. PubMed ID: 17717600
[TBL] [Abstract][Full Text] [Related]
24. Lipopolysaccharide induces lung fibroblast proliferation through Toll-like receptor 4 signaling and the phosphoinositide3-kinase-Akt pathway.
He Z; Gao Y; Deng Y; Li W; Chen Y; Xing S; Zhao X; Ding J; Wang X
PLoS One; 2012; 7(4):e35926. PubMed ID: 22563417
[TBL] [Abstract][Full Text] [Related]
25. A self-reinforcing regulatory network triggered by limiting IL-7 activates pre-BCR signaling and differentiation.
Ochiai K; Maienschein-Cline M; Mandal M; Triggs JR; Bertolino E; Sciammas R; Dinner AR; Clark MR; Singh H
Nat Immunol; 2012 Jan; 13(3):300-7. PubMed ID: 22267219
[TBL] [Abstract][Full Text] [Related]
26. Tungsten Blocks Murine B Lymphocyte Differentiation and Proliferation Through Downregulation of IL-7 Receptor/Pax5 Signaling.
Wu TH; Bolt AM; Chou H; Plourde D; De Jay N; Guilbert C; Young YK; Kleinman CL; Mann KK
Toxicol Sci; 2019 Jul; 170(1):45-56. PubMed ID: 30912803
[TBL] [Abstract][Full Text] [Related]
27. miR-29 Sustains B Cell Survival and Controls Terminal Differentiation via Regulation of PI3K Signaling.
Hines MJ; Coffre M; Mudianto T; Panduro M; Wigton EJ; Tegla C; Osorio-Vasquez V; Kageyama R; Benhamou D; Perez O; Bajwa S; McManus MT; Ansel KM; Melamed D; Koralov SB
Cell Rep; 2020 Dec; 33(9):108436. PubMed ID: 33264610
[TBL] [Abstract][Full Text] [Related]
28. Combined heterozygous loss of Ebf1 and Pax5 allows for T-lineage conversion of B cell progenitors.
Ungerbäck J; Åhsberg J; Strid T; Somasundaram R; Sigvardsson M
J Exp Med; 2015 Jun; 212(7):1109-23. PubMed ID: 26056231
[TBL] [Abstract][Full Text] [Related]
29. B cell receptor-ERK1/2 signal cancels PAX5-dependent repression of BLIMP1 through PAX5 phosphorylation: a mechanism of antigen-triggering plasma cell differentiation.
Yasuda T; Hayakawa F; Kurahashi S; Sugimoto K; Minami Y; Tomita A; Naoe T
J Immunol; 2012 Jun; 188(12):6127-34. PubMed ID: 22593617
[TBL] [Abstract][Full Text] [Related]
30. PTEN-Regulated AID Transcription in Germinal Center B Cells Is Essential for the Class-Switch Recombination and IgG Antibody Responses.
Wang J; Liu S; Hou B; Yang M; Dong Z; Qi H; Liu W
Front Immunol; 2018; 9():371. PubMed ID: 29541074
[TBL] [Abstract][Full Text] [Related]
31. Pax5: the guardian of B cell identity and function.
Cobaleda C; Schebesta A; Delogu A; Busslinger M
Nat Immunol; 2007 May; 8(5):463-70. PubMed ID: 17440452
[TBL] [Abstract][Full Text] [Related]
32. PAX5/TEL acts as a transcriptional repressor causing down-modulation of CD19, enhances migration to CXCL12, and confers survival advantage in pre-BI cells.
Fazio G; Palmi C; Rolink A; Biondi A; Cazzaniga G
Cancer Res; 2008 Jan; 68(1):181-9. PubMed ID: 18172310
[TBL] [Abstract][Full Text] [Related]
33. Reduced notch activity is associated with an impaired marginal zone B cell development and function in Sly1 mutant mice.
Scheikl T; Reis B; Pfeffer K; Holzmann B; Beer S
Mol Immunol; 2009 Feb; 46(5):969-77. PubMed ID: 18950867
[TBL] [Abstract][Full Text] [Related]
34. 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated impairment of B cell differentiation involves dysregulation of paired box 5 (Pax5) isoform, Pax5a.
Schneider D; Manzan MA; Crawford RB; Chen W; Kaminski NE
J Pharmacol Exp Ther; 2008 Aug; 326(2):463-74. PubMed ID: 18483191
[TBL] [Abstract][Full Text] [Related]
35. Context-specific BAFF-R signaling by the NF-κB and PI3K pathways.
Jellusova J; Miletic AV; Cato MH; Lin WW; Hu Y; Bishop GA; Shlomchik MJ; Rickert RC
Cell Rep; 2013 Nov; 5(4):1022-35. PubMed ID: 24239354
[TBL] [Abstract][Full Text] [Related]
36. Genetic analysis of the role of the PI3K-Akt pathway in lipopolysaccharide-induced cytokine and tissue factor gene expression in monocytes/macrophages.
Luyendyk JP; Schabbauer GA; Tencati M; Holscher T; Pawlinski R; Mackman N
J Immunol; 2008 Mar; 180(6):4218-26. PubMed ID: 18322234
[TBL] [Abstract][Full Text] [Related]
37. PI3K induces B-cell development and regulates B cell identity.
Abdelrasoul H; Werner M; Setz CS; Okkenhaug K; Jumaa H
Sci Rep; 2018 Jan; 8(1):1327. PubMed ID: 29358580
[TBL] [Abstract][Full Text] [Related]
38. Repression of the B cell identity factor Pax5 is not required for plasma cell development.
Liu GJ; Jaritz M; Wöhner M; Agerer B; Bergthaler A; Malin SG; Busslinger M
J Exp Med; 2020 Nov; 217(11):. PubMed ID: 32780801
[TBL] [Abstract][Full Text] [Related]
39. Early function of Pax5 (BSAP) before the pre-B cell receptor stage of B lymphopoiesis.
Thévenin C; Nutt SL; Busslinger M
J Exp Med; 1998 Aug; 188(4):735-44. PubMed ID: 9705955
[TBL] [Abstract][Full Text] [Related]
40. PTEN and PI-3 kinase inhibitors control LPS signaling and the lymphoproliferative response in the CD19+ B cell compartment.
Singh AR; Peirce SK; Joshi S; Durden DL
Exp Cell Res; 2014 Sep; 327(1):78-90. PubMed ID: 24881819
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
